Medicus Pharma Ltd.
Common Stock · NASDAQ
Live TMS charts are coming soon.
Paper trading. Simulated, no real money.
No public theses on MDCX yet. When TMS traders open paper trades on it and make their thesis public, the long and short split, average conviction and hit rate show here.
Key stats load once market data is connected.
Medicus Pharma filed an 8-K disclosing a notice of delisting or failure to meet a continued listing rule, along with a transfer of its listing. The filing signals listing compliance trouble that matters to holders.
Medicus Pharma has regained compliance with Nasdaq listing requirements, allowing it to continue its listing. The headline is the only detail available, so the specific deficiency and cure are not described.
Medicus Pharma says Nasdaq confirmed it regained compliance with the minimum shareholders' equity requirement for continued listing. The company cited $4.25 million in equity financings led by its CEO and a $10.5 million debt exchange.
No SEC financials for MDCX yet. Companies that file 10-K and 10-Q reports show revenue, earnings, cash flow and the balance sheet here.
Source: SEC filings (10-K, 10-Q).
Paper trading only. Nothing here is financial advice.